Literature DB >> 20617387

HIV and COPD: impact of risk behaviors and diseases on quality of life.

M Bradley Drummond1, Gregory D Kirk, Meredith C McCormack, Mariah M Marshall, Erin P Ricketts, Shruti H Mehta, Robert A Wise, Christian A Merlo.   

Abstract

PURPOSE: Smoking worsens quality of life among HIV-infected individuals, but it remains unclear if this association is related simply to smoking or to chronic obstructive pulmonary disease (COPD), the end-organ disease caused by smoking.
METHODS: Using cross-sectional data from the AIDS Linked to the Intravenous Experience study, we determined the independent effects of smoking, HIV and COPD assessed using the Medical Outcome Studies-HIV questionnaire.
RESULTS: Of 973 participants, 287 (29.5%) were HIV infected and 151 (15.5%) had spirometry-defined obstruction. Eight hundred and thirty-four (85.7%) were current smokers with 23.3 mean pack-years history. HIV infection was independently associated with reduced physical and mental health. COPD was associated with a trend toward worse physical health (-1.48 units; 95%CI -3.33 to 0.38; p = 0.12) and was independently associated with worse mental health (-2.43 units; 95%CI -4.22 to -0.64; p < 0.01). After accounting for COPD and other covariates, smoking was not associated with changes in physical or mental health.
CONCLUSIONS: The presence of COPD, rather than smoking, is associated with worse quality of life independent of HIV infection. Diagnosis and management of COPD in former or current smokers with or at risk for HIV may further improve quality of life.

Entities:  

Mesh:

Year:  2010        PMID: 20617387      PMCID: PMC4097077          DOI: 10.1007/s11136-010-9701-x

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  46 in total

Review 1.  Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines for chronic obstructive pulmonary disease.

Authors:  Federico P Gómez; Roberto Rodriguez-Roisin
Journal:  Curr Opin Pulm Med       Date:  2002-03       Impact factor: 3.155

Review 2.  HIV infection among intravenous drug users: epidemiology and risk reduction.

Authors:  D C Des Jarlais; S R Friedman
Journal:  AIDS       Date:  1987-07       Impact factor: 4.177

3.  Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection.

Authors:  J Turner; K Page-Shafer; D P Chin; D Osmond; M Mossar; L Markstein; J Huitsing; S Barnes; V Clemente; M Chesney
Journal:  AIDS Patient Care STDS       Date:  2001-12       Impact factor: 5.078

4.  Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV Cost and Services Utilization Study.

Authors:  R D Hays; W E Cunningham; C D Sherbourne; I B Wilson; A W Wu; P D Cleary; D F McCaffrey; J A Fleishman; S Crystal; R Collins; F Eggan; M F Shapiro; S A Bozzette
Journal:  Am J Med       Date:  2000-06-15       Impact factor: 4.965

Review 5.  Psychometric evaluation of four HIV disease-specific quality-of-life instruments.

Authors:  E A Davis; D S Pathak
Journal:  Ann Pharmacother       Date:  2001-05       Impact factor: 3.154

6.  The use of 2 health-related quality-of-life measures in a sample of persons infected with human immunodeficiency virus.

Authors:  T Delate; S J Coons
Journal:  Clin Infect Dis       Date:  2001-01-25       Impact factor: 9.079

7.  Health-related quality of life predicts survival, cytomegalovirus disease, and study retention in clinical trial participants with advanced HIV disease.

Authors:  Denise L Jacobson; Albert W Wu; Judith Feinberg
Journal:  J Clin Epidemiol       Date:  2003-09       Impact factor: 6.437

8.  Alteration of pulmonary function in intravenous drug abusers. Prevalence, severity, and characterization of gas exchange abnormalities.

Authors:  E S Overland; A J Nolan; P C Hopewell
Journal:  Am J Med       Date:  1980-02       Impact factor: 4.965

9.  A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection.

Authors:  A W Wu; H R Rubin; W C Mathews; J E Ware; L T Brysk; W D Hardy; S A Bozzette; S A Spector; D D Richman
Journal:  Med Care       Date:  1991-08       Impact factor: 2.983

10.  Illness representation and smoking behavior: a focus group study of HIV-positive men.

Authors:  Nancy R Reynolds; Judith L Neidig; Mary E Wewers
Journal:  J Assoc Nurses AIDS Care       Date:  2004 Jul-Aug       Impact factor: 1.354

View more
  13 in total

Review 1.  Health-related quality of life assessment after antiretroviral therapy: a review of the literature.

Authors:  Harleen Gakhar; Amanda Kamali; Mark Holodniy
Journal:  Drugs       Date:  2013-05       Impact factor: 9.546

Review 2.  Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management.

Authors:  Nirupama Putcha; M Bradley Drummond; Robert A Wise; Nadia N Hansel
Journal:  Semin Respir Crit Care Med       Date:  2015-08-03       Impact factor: 3.119

3.  Risk factors associated with acute exacerbation of chronic obstructive pulmonary disease in HIV-infected and uninfected patients.

Authors:  Timothy B Depp; Kathleen A McGinnis; Kevin Kraemer; Kathleen M Akgün; E Jennifer Edelman; David A Fiellin; Adeel A Butt; Stephen Crystal; Adam J Gordon; Matthew Freiberg; Cynthia L Gibert; David Rimland; Kendall J Bryant; Kristina Crothers
Journal:  AIDS       Date:  2016-01-28       Impact factor: 4.177

Review 4.  Effects of smoking on non-AIDS-related morbidity in HIV-infected patients.

Authors:  Daniel K Shirley; Robert J Kaner; Marshall J Glesby
Journal:  Clin Infect Dis       Date:  2013-04-09       Impact factor: 9.079

5.  HIV infection is associated with diffusing capacity impairment in women.

Authors:  Meghan E Fitzpatrick; Matthew R Gingo; Cathy Kessinger; Lorrie Lucht; Eric Kleerup; Ruth M Greenblatt; David Claman; Claudia Ponath; Serena Fong; Laurence Huang; Alison Morris
Journal:  J Acquir Immune Defic Syndr       Date:  2013-11-01       Impact factor: 3.731

6.  Chest computed tomography findings in HIV-infected individuals in the era of antiretroviral therapy.

Authors:  Emily Clausen; Catherine Wittman; Matthew Gingo; Khaled Fernainy; Carl Fuhrman; Cathy Kessinger; Renee Weinman; Deborah McMahon; Joseph Leader; Alison Morris
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

Review 7.  A Systematic Review of the Prevalence and Pattern of Imaging Defined Post-TB Lung Disease.

Authors:  Jamilah Meghji; Hope Simpson; S Bertel Squire; Kevin Mortimer
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

8.  Association of Lung Function With HIV-Related Quality of Life and Health Care Utilization in a High-Risk Cohort.

Authors:  Sarath Raju; Meredith C McCormack; Michael Bradley Drummond; Hema C Ramamurthi; Christian A Merlo; Robert A Wise; Shruti H Mehta; Robert H Brown; Gregory D Kirk
Journal:  J Acquir Immune Defic Syndr       Date:  2020-10-01       Impact factor: 3.771

9.  Pulmonary symptoms and diagnoses are associated with HIV in the MACS and WIHS cohorts.

Authors:  Matthew R Gingo; Goundappa K Balasubramani; Thomas B Rice; Lawrence Kingsley; Eric C Kleerup; Roger Detels; Eric C Seaberg; Ruth M Greenblatt; Susan Holman; Laurence Huang; Sarah H Sutton; Marnie Bertolet; Alison Morris
Journal:  BMC Pulm Med       Date:  2014-04-30       Impact factor: 3.317

10.  A randomized study of contingency management and spirometric lung age for motivating smoking cessation among injection drug users.

Authors:  Michael B Drummond; Jacquie Astemborski; Allison A Lambert; Scott Goldberg; Maxine L Stitzer; Christian A Merlo; Cynthia S Rand; Robert A Wise; Gregory D Kirk
Journal:  BMC Public Health       Date:  2014-07-28       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.